Investigation of the effect of salt additives in Protein L affinity chromatography for the purification of tandem single-chain variable fragment bispecific antibodies
Bispecific antibody;
tandem single-chain variable fragment;
purification;
affinity chromatography;
high molecular weight;
L-Arginine monohydrochloride;
NILE RED;
ARGININE;
BLINATUMOMAB;
CONSTRUCT;
ELUTION;
COLUMN;
LIGHT;
PROBE;
D O I:
10.1080/19420862.2020.1718440
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Tandem single-chain variable fragment (scFv) bispecific antibodies (bsAb) are one of the most promising bsAb formats reported thus far. Yet, because of their increased aggregation propensity, high impurity content due to low expression level, smaller size and lack of the Fc region, it is challenging to isolate these products with high yield and purity within a limited number of purification steps in a scalable fashion. A robust purification process that is able to circumvent these issues is therefore of critical importance to allow effective isolation of this group of antibodies. We investigated the addition of sodium chloride (NaCl), calcium chloride (CaCl2), and L-arginine monohydrochloride (Arg center dot HCl) to the elution buffer of Protein L affinity chromatography, and propose here a novel mechanism for the modification of Protein L binding avidity that can lead to enhanced high molecular weight (HMW)-monomer separation, a preferential strengthening effect of the HMW-Protein L interaction compared to the monomer-Protein L interaction. In particular, we found Arg center dot HCl to be the most effective salt additive in terms of purity and recovery. The mechanism we propose is different from the widely reported chaotropic effect exerted by salt additives observed in Protein A chromatography. We also demonstrate here that a final eluate containing <1% HMW species and <100 ppm host cell proteins can be obtained within a two-step process with an overall yield of 65%, highlighting the promising suitability of Protein L affinity chromatography for the purification of kappa light chain-containing tandem scFv bsAb.
机构:
Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Penzberg, GermanyRoche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Penzberg, Germany
Brinkmann, Ulrich
Kontermann, Roland E.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, Stuttgart, BW, Germany
Univ Stuttgart, Stuttgart Res Ctr Syst Biol, Nobelstr, Stuttgart, GermanyRoche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Penzberg, Germany
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Thermo Fisher Sci, Biosci Div, Guangzhou, Guangdong, Peoples R ChinaChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Chen, Chen
Wakabayashi, Tetsuya
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmaceut Co Ltd, Discovery Biol Dept, Res Div, Gotemba, Shizuoka, JapanChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Wakabayashi, Tetsuya
Muraoka, Masaru
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Muraoka, Masaru
Shu, Feng
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Shu, Feng
Shan, Chia Wei
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Shan, Chia Wei
Kun, Chong Chor
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Kun, Chong Chor
Jang, Ching Tim
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Jang, Ching Tim
Soehano, Ishin
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Soehano, Ishin
Shimizu, Yuichiro
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Chugai Pharmaceut Co Ltd, Discovery Biol Dept, Res Div, Gotemba, Shizuoka, JapanChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Shimizu, Yuichiro
Igawa, Tomoyuki
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmaceut Co Ltd, Discovery Biol Dept, Res Div, Gotemba, Shizuoka, Japan
Chugai Pharmabody Res Pte Ltd, Res Div, Synapse, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Igawa, Tomoyuki
Nezu, Jun-Ichi
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmaceut Co Ltd, Res Div, Kanagawa, Kanagawa, JapanChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
机构:
Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Penzberg, GermanyRoche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Penzberg, Germany
Brinkmann, Ulrich
Kontermann, Roland E.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, Stuttgart, BW, Germany
Univ Stuttgart, Stuttgart Res Ctr Syst Biol, Nobelstr, Stuttgart, GermanyRoche Innovat Ctr Munich, Roche Pharma Res & Early Dev pRED, Penzberg, Germany
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Thermo Fisher Sci, Biosci Div, Guangzhou, Guangdong, Peoples R ChinaChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Chen, Chen
Wakabayashi, Tetsuya
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmaceut Co Ltd, Discovery Biol Dept, Res Div, Gotemba, Shizuoka, JapanChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Wakabayashi, Tetsuya
Muraoka, Masaru
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Muraoka, Masaru
Shu, Feng
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Shu, Feng
Shan, Chia Wei
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Shan, Chia Wei
Kun, Chong Chor
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Kun, Chong Chor
Jang, Ching Tim
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Jang, Ching Tim
Soehano, Ishin
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Soehano, Ishin
Shimizu, Yuichiro
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Chugai Pharmaceut Co Ltd, Discovery Biol Dept, Res Div, Gotemba, Shizuoka, JapanChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Shimizu, Yuichiro
Igawa, Tomoyuki
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmaceut Co Ltd, Discovery Biol Dept, Res Div, Gotemba, Shizuoka, Japan
Chugai Pharmabody Res Pte Ltd, Res Div, Synapse, SingaporeChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore
Igawa, Tomoyuki
Nezu, Jun-Ichi
论文数: 0引用数: 0
h-index: 0
机构:
Chugai Pharmaceut Co Ltd, Res Div, Kanagawa, Kanagawa, JapanChugai Pharmabody Res Pte Ltd, Antibody Generat Grp, Res Div, Singapore, Singapore